ArticleNPJ breast cancer2024

Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.

Dongshao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.